Olivia Spleiss

3.0k total citations
28 papers, 971 citations indexed

About

Olivia Spleiss is a scholar working on Oncology, Molecular Biology and Immunology. According to data from OpenAlex, Olivia Spleiss has authored 28 papers receiving a total of 971 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 10 papers in Molecular Biology and 9 papers in Immunology. Recurrent topics in Olivia Spleiss's work include Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Melanoma and MAPK Pathways (5 papers) and Immune Response and Inflammation (5 papers). Olivia Spleiss is often cited by papers focused on Neuroinflammation and Neurodegeneration Mechanisms (5 papers), Melanoma and MAPK Pathways (5 papers) and Immune Response and Inflammation (5 papers). Olivia Spleiss collaborates with scholars based in Switzerland, Germany and United States. Olivia Spleiss's co-authors include Bernd L. Fiebich, Michael Hüll, Erik Boddeke, Thomas Berger, Dietrich van Calker, Stefan Frentzel, Peter Gebicke-Härter, Manuel Buttini, Jeffrey K. Harrison and Kerstin Trunzer and has published in prestigious journals such as Journal of Clinical Oncology, Blood and Cancer Research.

In The Last Decade

Olivia Spleiss

28 papers receiving 950 citations

Peers

Olivia Spleiss
David Martín‐Oliva Spain
Sophie Daburon France
Piero Alò Italy
Marc Bigaud Switzerland
Guy Meno‐Tetang United States
Viktor Stránecký Czechia
Deepak Nihalani United States
Rotem Ben‐Hamo Israel
Heonjong Han South Korea
Caishu Deng United States
David Martín‐Oliva Spain
Olivia Spleiss
Citations per year, relative to Olivia Spleiss Olivia Spleiss (= 1×) peers David Martín‐Oliva

Countries citing papers authored by Olivia Spleiss

Since Specialization
Citations

This map shows the geographic impact of Olivia Spleiss's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Olivia Spleiss with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Olivia Spleiss more than expected).

Fields of papers citing papers by Olivia Spleiss

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Olivia Spleiss. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Olivia Spleiss. The network helps show where Olivia Spleiss may publish in the future.

Co-authorship network of co-authors of Olivia Spleiss

This figure shows the co-authorship network connecting the top 25 collaborators of Olivia Spleiss. A scholar is included among the top collaborators of Olivia Spleiss based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Olivia Spleiss. Olivia Spleiss is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Alioto, Tyler, Fernando Cruz, Jèssica Gómez‐Garrido, et al.. (2019). The Genome Sequence of the Eastern Woodchuck (Marmota monax) – A Preclinical Animal Model for Chronic Hepatitis B. G3 Genes Genomes Genetics. 9(12). 3943–3952. 9 indexed citations
2.
Pao, William, Chia-Huey Ooi, Fabian Birzele, et al.. (2018). Tissue-Specific Immunoregulation: A Call for Better Understanding of the “Immunostat” in the Context of Cancer. Cancer Discovery. 8(4). 395–402. 63 indexed citations
3.
Klughammer, Barbara, Wolfram Brugger, Federico Cappuzzo, et al.. (2016). Examining Treatment Outcomes with Erlotinib in Patients with Advanced Non–Small Cell Lung Cancer Whose Tumors Harbor Uncommon EGFR Mutations. Journal of Thoracic Oncology. 11(4). 545–555. 78 indexed citations
4.
5.
Grabole, Nils, Jitao David Zhang, Stefan Aigner, et al.. (2016). Genomic analysis of the molecular neuropathology of tuberous sclerosis using a human stem cell model. Genome Medicine. 8(1). 94–94. 37 indexed citations
6.
Fowler, Stephen, Heidemarie Kletzl, Moshe Finel, et al.. (2014). A UGT2B10 Splicing Polymorphism Common in African Populations May Greatly Increase Drug Exposure. Journal of Pharmacology and Experimental Therapeutics. 352(2). 358–367. 47 indexed citations
7.
Lacouture, Mario E., Madeleine Duvic, Axel Hauschild, et al.. (2013). Analysis of Dermatologic Events in Vemurafenib-Treated Patients With Melanoma. The Oncologist. 18(3). 314–322. 156 indexed citations
8.
Lee, Janet, Jianmei Wang, Mitchell Martin, et al.. (2011). Genetic variation in UGT1A1 typical of Gilbert syndrome is associated with unconjugated hyperbilirubinemia in patients receiving tocilizumab. Pharmacogenetics and Genomics. 21(7). 365–374. 18 indexed citations
9.
Klughammer, Barbara & Olivia Spleiss. (2011). PP 71 ‘Other’ (non-activating, non-T790M) EGFR mutations and their clinical implications collected from various Tarceva trials in NSCLC. European Journal of Cancer. 47. S20–S21. 2 indexed citations
10.
Grinyó, Josep M., Yves Vanrenterghem, Björn Nashan, et al.. (2008). Association of four DNA polymorphisms with acute rejection after kidney transplantation. Transplant International. 21(9). 879–891. 94 indexed citations
11.
Laack, Eckart, Thorsten Gutjahr, Ernst Heinmöller, et al.. (2007). Association between different potential predictive markers from TRUST, a trial of erlotinib in non-small cell lung cancer (NSCLC). Journal of Clinical Oncology. 25(18_suppl). 7651–7651. 5 indexed citations
12.
13.
Gebicke-Haerter, P.J., et al.. (2001). Microglial chemokines and chemokine receptors. Progress in brain research. 132. 525–532. 27 indexed citations
14.
Kitamura, Yoshihisa, Olivia Spleiss, Hongwei Li, et al.. (2001). Lipopolysaccharide‐induced switch between retinoid receptor (RXR) α and glucocorticoid attenuated response gene (GARG)‐16 messenger RNAs in cultured rat microglia. Journal of Neuroscience Research. 64(6). 553–563. 14 indexed citations
15.
16.
17.
Boddeke, Erik, Stefan Frentzel, Jeffrey K. Harrison, et al.. (1999). Cultured rat microglia express functional β-chemokine receptors. Journal of Neuroimmunology. 98(2). 176–184. 102 indexed citations
18.
Spleiss, Olivia, et al.. (1998). Abnormal G protein αs- and αi2-subunit mRNA expression in bipolar affective disorder. Molecular Psychiatry. 3(6). 512–520. 38 indexed citations
19.
Spleiss, Olivia, Kurt Appel, H.W.G.M. Boddeke, Thomas Berger, & Peter J. Gebicke‐Haerter. (1998). Molecular biology of microglia cytokine and chemokine receptors and microglial activation. Life Sciences. 62(17-18). 1707–1710. 10 indexed citations
20.
Spleiss, Olivia, et al.. (1998). Cloning of rat HIV-1-chemokine coreceptor CKR5 from microglia and upregulation of its mRNA in ischemic and endotoxinemic rat brain. Journal of Neuroscience Research. 53(1). 16–28. 41 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by David Martín‐Oliva Breakdown of academic impact, for papers by Sophie Daburon Breakdown of academic impact, for papers by Piero Alò Breakdown of academic impact, for papers by Marc Bigaud Breakdown of academic impact, for papers by Guy Meno‐Tetang Breakdown of academic impact, for papers by Viktor Stránecký Breakdown of academic impact, for papers by Deepak Nihalani Breakdown of academic impact, for papers by Rotem Ben‐Hamo Breakdown of academic impact, for papers by Heonjong Han Breakdown of academic impact, for papers by Caishu Deng
Rankless by CCL
2026